Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

NCT02223117 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Thrombosomes
BIOLOGICAL: Placebo

Sponsor

Cellphire Therapeutics, Inc.

Collaborators

[object Object]